Tradewinds LLC’s Bristol-Myers Squibb BMY Stock Holding History

Tradewinds LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$320K	Buy	5,504 +37	+0.7%	+$2.16K	0.1%	101
2025 Q4	$295K	Sell	5,467 -18	-0.3%	-$866	0.07%	159
2025 Q3	$247K	Buy	+5,485	New	+$256K	0.06%	181
2025 Q2	–	Sell	-5,042	Closed	-$308K	–	99
2025 Q1	$308K	Hold	5,042	–	–	0.09%	154
2024 Q4	$283K	Buy	+5,042	New	+$282K	0.08%	164
2024 Q3	–	Sell	-4,948	Closed	-$205K	–	166
2024 Q2	$205K	Buy	+4,948	New	+$221K	0.06%	200
2023 Q3	$233K	Sell	4,008 -2	-0%	-$123	0.14%	108
2023 Q2	$256K	Buy	4,010 +751	+23%	+$50.4K	0.15%	89
2023 Q1	$226K	Buy	+3,259	New	+$230K	0.14%	109
2022 Q4	–	Sell	-2,943	Closed	-$209K	–	132
2022 Q3	$209K	Buy	2,943 +39	+1%	+$2.83K	0.15%	104
2022 Q2	$224K	Buy	+2,904	New	+$221K	0.15%	105

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tradewinds LLC's BMY Position: Q1 2026 in Review

Tradewinds LLC increased its Bristol-Myers Squibb (BMY) stake by 0.68% in Q1 2026, buying an estimated $2.16K and bringing the position to 5,504 shares worth $320K. The position accounts for 0.1% of the portfolio, ranked #101.

Tradewinds LLC first reported a position in BMY in Q2 2022 and has held it in 11 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Tradewinds LLC held 5,504 shares of Bristol-Myers Squibb worth $320K as of Q1 2026.
Tradewinds LLC bought 37 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.16K.
Bristol-Myers Squibb made up 0.1% of Tradewinds LLC's portfolio in Q1 2026, its #101 holding.
Tradewinds LLC first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 11 quarters since.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tradewinds LLC's 13F filing for Q1 2026, filed 4 May 2026.